SHINSHU UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1949-05-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.shinshu-u.ac.jp
Clinical Trials
167
Active:0
Completed:77
Trial Phases
4 Phases
Phase 1:6
Phase 2:10
Phase 4:5
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (165 trials with phase data)• Click on a phase to view related trials
Not Applicable
144 (87.3%)Phase 2
10 (6.1%)Phase 1
6 (3.6%)Phase 4
5 (3.0%)Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
Phase 2
Recruiting
- Conditions
- T2DM (Type 2 Diabetes Mellitus)SGLT2-InhibitorsMetformin
- Interventions
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- Shinshu University
- Target Recruit Count
- 120
- Registration Number
- NCT05469659
- Locations
- 🇯🇵
Shinshu University, Matsumoto, Nagano, Japan
Usefulness of Non TNF Usage in RA Patients
Phase 2
Recruiting
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2018-12-21
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Shinshu University
- Target Recruit Count
- 90
- Registration Number
- NCT03784261
- Locations
- 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan
Examination of Efficacy and Safety of Baricitinib in RA Patients
Phase 2
Recruiting
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Shinshu University
- Target Recruit Count
- 90
- Registration Number
- NCT03755466
- Locations
- 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan
Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients
Phase 2
Recruiting
- Conditions
- Osteoporosis
- Interventions
- Drug: SERM "Viviant®Tablet 20mg" and ELD "Edirol®Tablet 0.75ug"Drug: Bisphosphonates and ELD "Edirol®Tablet 0.75ug"Drug: ELD "Edirol®Tablet 0.75ug"
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Shinshu University
- Target Recruit Count
- 90
- Registration Number
- NCT03755193
- Locations
- 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan
Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy
Phase 2
Recruiting
- Conditions
- Osteoporosis
- Interventions
- Drug: "Teriparatide", "Forteo® or Teribon"
- First Posted Date
- 2018-10-10
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Shinshu University
- Target Recruit Count
- 90
- Registration Number
- NCT03702140
- Locations
- 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found